Home > Resources > Whitepapers > FUJITSU Integrated System PRIMEFLEX® for Hadoop: Genome Analysis

FUJITSU Integrated System PRIMEFLEX® for Hadoop: Genome Analysis

December 4, 2016

FUJITSU Integrated System PRIMEFLEX for Hadoop offers end-to-end integration from strategic consulting to use case development and implementation services for specific customer needs. Read how PRIMEFLEX for Hadoop is making an impact on The German Cancer Research Centre for more efficient genome analysis.

Spotlight

MichBio

MichBio is a non-profit association representing more than 600 bioscience companies, universities and academic institutions dedicated to advancing Michigan's bioscience industry. MichBio is the state's leading advocate for the bio-industry. MichBio fosters an environment that educates the public and policy makers, influences public policy and advances the economic interests of its member companies and the industry as a whole.

OTHER WHITEPAPERS

Cell Lysate Sample Handling with Simoa Bead-Based Assays

whitePaper | November 12, 2019

This document describes a novel Quanterix lysate diluent for running lysate samples with Simoa assays diluent.

Read More

Biopharmaceutical Sector

whitePaper | May 29, 2023

tronger than expected US inflation and a bump in consumer spending have fuelled worldwide expectations that interest rates will go higher, as predictions about future monetary policy rapidly shift.

Read More

Asia Pacific – Clinical trial landscape

whitePaper | November 28, 2022

The Asia-Pacific area is home to around two thirds of the world’s population and has a wide range of cultural, political, economic, and other factors that affect vaccine development, use, and registration.

Read More

Genetic insights for biopharmaceuticals: Propelling drug candidates into therapeutic assets

whitePaper | March 9, 2023

For biopharmaceutical and biotechnology companies, innovation is imperative. Economic growth in these industries relies heavily upon investment in product development—perhaps more so than any other industry

Read More

Cell and Gene Therapy Clinical Trials

whitePaper | November 8, 2022

Using experienced-based best practices and documented tools, ICON has conducted over 63 CGT trials across multiple therapeutic areas from haematology-oncology torare and orphan diseases.

Read More

Synthetic Biology Biotechnology and AgTech

whitePaper | March 12, 2022

CRISPR, gene editing, biotech, precision agriculture and automation influencing the future of business, government, food, medicine, geopolitics and society

Read More

Cell Lysate Sample Handling with Simoa Bead-Based Assays

whitePaper | November 12, 2019

This document describes a novel Quanterix lysate diluent for running lysate samples with Simoa assays diluent.

Read More

Biopharmaceutical Sector

whitePaper | May 29, 2023

tronger than expected US inflation and a bump in consumer spending have fuelled worldwide expectations that interest rates will go higher, as predictions about future monetary policy rapidly shift.

Read More

Asia Pacific – Clinical trial landscape

whitePaper | November 28, 2022

The Asia-Pacific area is home to around two thirds of the world’s population and has a wide range of cultural, political, economic, and other factors that affect vaccine development, use, and registration.

Read More

Genetic insights for biopharmaceuticals: Propelling drug candidates into therapeutic assets

whitePaper | March 9, 2023

For biopharmaceutical and biotechnology companies, innovation is imperative. Economic growth in these industries relies heavily upon investment in product development—perhaps more so than any other industry

Read More

Cell and Gene Therapy Clinical Trials

whitePaper | November 8, 2022

Using experienced-based best practices and documented
tools, ICON has conducted over 63 CGT trials across
multiple therapeutic areas from haematology-oncology torare and orphan diseases.

Read More

Synthetic Biology Biotechnology and AgTech

whitePaper | March 12, 2022

CRISPR, gene editing, biotech, precision agriculture and automation influencing the future of business, government, food, medicine, geopolitics and society

Read More

More Whitepapers

Spotlight

MichBio

MichBio is a non-profit association representing more than 600 bioscience companies, universities and academic institutions dedicated to advancing Michigan's bioscience industry. MichBio is the state's leading advocate for the bio-industry. MichBio fosters an environment that educates the public and policy makers, influences public policy and advances the economic interests of its member companies and the industry as a whole.

Events

8th International Conference on Bio-Sensing Technology

Conference

8th International Conference on Bio-Sensing Technology

Conference